The global Halofuginone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
该品与常山（一种用于疟疾病的中药）中所含的喹唑啉生物碱常山碱类似。卤夫酮具有强大的杀球虫活性，为高效抗球虫卵囊全部杀死，具有广谱、高效、低毒、不易产生耐药性的特点，在养鸡业使用较多。
As a new broad-spectrum anti coccidiosis drug, Halofuginone has the advantages of small dosage and no cross resistance with other anti coccidiosis drugs. The product has obvious inhibitory effect on the early reproductive spores and the first and second generation schizoites of coccidia, and can control the oocyst discharge, reducing the possibility of reinfection. The peak period of action was 2 to 3 days after infection. The product has strong inhibition effect on 6 kinds of chicken Eimeria and 2 kinds of turkey Eimeria which are the most harmful, and it also has inhibition effect on rabbit Eimeria. Its anti coccidiosis activity is higher than polyether antibiotics. It is also effective against Sarcocystis ovis and Pyroplasma taylor.
The “Halofuginone Industry Forecast” looks at past sales and reviews total world Halofuginone sales in 2024, providing a comprehensive analysis by region and market sector of projected Halofuginone sales for 2025 through 2031. With Halofuginone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Halofuginone industry.
This Insight Report provides a comprehensive analysis of the global Halofuginone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Halofuginone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Halofuginone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Halofuginone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Halofuginone.
This report presents a comprehensive overview, market shares, and growth opportunities of Halofuginone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
95% Purity
97% Purity
98% Purity
99% Purity
Segmentation by Application:
Aquaculture
Agriculture
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Synchem
Madision
Shaghain Yuanye
Dalian Meilun
Yingnor
HanHong
Tautobiotech
Sunlidabio
Bidepharm
Finetechchem
Nanjing Romanme
Acmechem
Accel Pharmtech
Biorbyt
Molcan Corporation
ChemScene
Crysdot
ChemShuttle
Arctom
Pharma Affiliates
Leancare
Key Questions Addressed in this Report
What is the 10-year outlook for the global Halofuginone market?
What factors are driving Halofuginone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Halofuginone market opportunities vary by end market size?
How does Halofuginone break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Halofuginone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Halofuginone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Halofuginone by Country/Region, 2020, 2024 & 2031
2.2 Halofuginone Segment by Type
2.2.1 95% Purity
2.2.2 97% Purity
2.2.3 98% Purity
2.2.4 99% Purity
2.3 Halofuginone Sales by Type
2.3.1 Global Halofuginone Sales Market Share by Type (2020-2025)
2.3.2 Global Halofuginone Revenue and Market Share by Type (2020-2025)
2.3.3 Global Halofuginone Sale Price by Type (2020-2025)
2.4 Halofuginone Segment by Application
2.4.1 Aquaculture
2.4.2 Agriculture
2.5 Halofuginone Sales by Application
2.5.1 Global Halofuginone Sale Market Share by Application (2020-2025)
2.5.2 Global Halofuginone Revenue and Market Share by Application (2020-2025)
2.5.3 Global Halofuginone Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Halofuginone Breakdown Data by Company
3.1.1 Global Halofuginone Annual Sales by Company (2020-2025)
3.1.2 Global Halofuginone Sales Market Share by Company (2020-2025)
3.2 Global Halofuginone Annual Revenue by Company (2020-2025)
3.2.1 Global Halofuginone Revenue by Company (2020-2025)
3.2.2 Global Halofuginone Revenue Market Share by Company (2020-2025)
3.3 Global Halofuginone Sale Price by Company
3.4 Key Manufacturers Halofuginone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Halofuginone Product Location Distribution
3.4.2 Players Halofuginone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Halofuginone by Geographic Region
4.1 World Historic Halofuginone Market Size by Geographic Region (2020-2025)
4.1.1 Global Halofuginone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Halofuginone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Halofuginone Market Size by Country/Region (2020-2025)
4.2.1 Global Halofuginone Annual Sales by Country/Region (2020-2025)
4.2.2 Global Halofuginone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Halofuginone Sales Growth
4.4 APAC Halofuginone Sales Growth
4.5 Europe Halofuginone Sales Growth
4.6 Middle East & Africa Halofuginone Sales Growth
5 Americas
5.1 Americas Halofuginone Sales by Country
5.1.1 Americas Halofuginone Sales by Country (2020-2025)
5.1.2 Americas Halofuginone Revenue by Country (2020-2025)
5.2 Americas Halofuginone Sales by Type (2020-2025)
5.3 Americas Halofuginone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Halofuginone Sales by Region
6.1.1 APAC Halofuginone Sales by Region (2020-2025)
6.1.2 APAC Halofuginone Revenue by Region (2020-2025)
6.2 APAC Halofuginone Sales by Type (2020-2025)
6.3 APAC Halofuginone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Halofuginone by Country
7.1.1 Europe Halofuginone Sales by Country (2020-2025)
7.1.2 Europe Halofuginone Revenue by Country (2020-2025)
7.2 Europe Halofuginone Sales by Type (2020-2025)
7.3 Europe Halofuginone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Halofuginone by Country
8.1.1 Middle East & Africa Halofuginone Sales by Country (2020-2025)
8.1.2 Middle East & Africa Halofuginone Revenue by Country (2020-2025)
8.2 Middle East & Africa Halofuginone Sales by Type (2020-2025)
8.3 Middle East & Africa Halofuginone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Halofuginone
10.3 Manufacturing Process Analysis of Halofuginone
10.4 Industry Chain Structure of Halofuginone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Halofuginone Distributors
11.3 Halofuginone Customer
12 World Forecast Review for Halofuginone by Geographic Region
12.1 Global Halofuginone Market Size Forecast by Region
12.1.1 Global Halofuginone Forecast by Region (2026-2031)
12.1.2 Global Halofuginone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Halofuginone Forecast by Type (2026-2031)
12.7 Global Halofuginone Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Synchem
13.1.1 Synchem Company Information
13.1.2 Synchem Halofuginone Product Portfolios and Specifications
13.1.3 Synchem Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Synchem Main Business Overview
13.1.5 Synchem Latest Developments
13.2 Madision
13.2.1 Madision Company Information
13.2.2 Madision Halofuginone Product Portfolios and Specifications
13.2.3 Madision Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Madision Main Business Overview
13.2.5 Madision Latest Developments
13.3 Shaghain Yuanye
13.3.1 Shaghain Yuanye Company Information
13.3.2 Shaghain Yuanye Halofuginone Product Portfolios and Specifications
13.3.3 Shaghain Yuanye Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shaghain Yuanye Main Business Overview
13.3.5 Shaghain Yuanye Latest Developments
13.4 Dalian Meilun
13.4.1 Dalian Meilun Company Information
13.4.2 Dalian Meilun Halofuginone Product Portfolios and Specifications
13.4.3 Dalian Meilun Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dalian Meilun Main Business Overview
13.4.5 Dalian Meilun Latest Developments
13.5 Yingnor
13.5.1 Yingnor Company Information
13.5.2 Yingnor Halofuginone Product Portfolios and Specifications
13.5.3 Yingnor Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Yingnor Main Business Overview
13.5.5 Yingnor Latest Developments
13.6 HanHong
13.6.1 HanHong Company Information
13.6.2 HanHong Halofuginone Product Portfolios and Specifications
13.6.3 HanHong Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 HanHong Main Business Overview
13.6.5 HanHong Latest Developments
13.7 Tautobiotech
13.7.1 Tautobiotech Company Information
13.7.2 Tautobiotech Halofuginone Product Portfolios and Specifications
13.7.3 Tautobiotech Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tautobiotech Main Business Overview
13.7.5 Tautobiotech Latest Developments
13.8 Sunlidabio
13.8.1 Sunlidabio Company Information
13.8.2 Sunlidabio Halofuginone Product Portfolios and Specifications
13.8.3 Sunlidabio Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sunlidabio Main Business Overview
13.8.5 Sunlidabio Latest Developments
13.9 Bidepharm
13.9.1 Bidepharm Company Information
13.9.2 Bidepharm Halofuginone Product Portfolios and Specifications
13.9.3 Bidepharm Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Bidepharm Main Business Overview
13.9.5 Bidepharm Latest Developments
13.10 Finetechchem
13.10.1 Finetechchem Company Information
13.10.2 Finetechchem Halofuginone Product Portfolios and Specifications
13.10.3 Finetechchem Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Finetechchem Main Business Overview
13.10.5 Finetechchem Latest Developments
13.11 Nanjing Romanme
13.11.1 Nanjing Romanme Company Information
13.11.2 Nanjing Romanme Halofuginone Product Portfolios and Specifications
13.11.3 Nanjing Romanme Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Nanjing Romanme Main Business Overview
13.11.5 Nanjing Romanme Latest Developments
13.12 Acmechem
13.12.1 Acmechem Company Information
13.12.2 Acmechem Halofuginone Product Portfolios and Specifications
13.12.3 Acmechem Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Acmechem Main Business Overview
13.12.5 Acmechem Latest Developments
13.13 Accel Pharmtech
13.13.1 Accel Pharmtech Company Information
13.13.2 Accel Pharmtech Halofuginone Product Portfolios and Specifications
13.13.3 Accel Pharmtech Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Accel Pharmtech Main Business Overview
13.13.5 Accel Pharmtech Latest Developments
13.14 Biorbyt
13.14.1 Biorbyt Company Information
13.14.2 Biorbyt Halofuginone Product Portfolios and Specifications
13.14.3 Biorbyt Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Biorbyt Main Business Overview
13.14.5 Biorbyt Latest Developments
13.15 Molcan Corporation
13.15.1 Molcan Corporation Company Information
13.15.2 Molcan Corporation Halofuginone Product Portfolios and Specifications
13.15.3 Molcan Corporation Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Molcan Corporation Main Business Overview
13.15.5 Molcan Corporation Latest Developments
13.16 ChemScene
13.16.1 ChemScene Company Information
13.16.2 ChemScene Halofuginone Product Portfolios and Specifications
13.16.3 ChemScene Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 ChemScene Main Business Overview
13.16.5 ChemScene Latest Developments
13.17 Crysdot
13.17.1 Crysdot Company Information
13.17.2 Crysdot Halofuginone Product Portfolios and Specifications
13.17.3 Crysdot Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Crysdot Main Business Overview
13.17.5 Crysdot Latest Developments
13.18 ChemShuttle
13.18.1 ChemShuttle Company Information
13.18.2 ChemShuttle Halofuginone Product Portfolios and Specifications
13.18.3 ChemShuttle Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 ChemShuttle Main Business Overview
13.18.5 ChemShuttle Latest Developments
13.19 Arctom
13.19.1 Arctom Company Information
13.19.2 Arctom Halofuginone Product Portfolios and Specifications
13.19.3 Arctom Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Arctom Main Business Overview
13.19.5 Arctom Latest Developments
13.20 Pharma Affiliates
13.20.1 Pharma Affiliates Company Information
13.20.2 Pharma Affiliates Halofuginone Product Portfolios and Specifications
13.20.3 Pharma Affiliates Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Pharma Affiliates Main Business Overview
13.20.5 Pharma Affiliates Latest Developments
13.21 Leancare
13.21.1 Leancare Company Information
13.21.2 Leancare Halofuginone Product Portfolios and Specifications
13.21.3 Leancare Halofuginone Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Leancare Main Business Overview
13.21.5 Leancare Latest Developments
14 Research Findings and Conclusion
?
?
*If Applicable.
